Articoli con mandati relativi all'accesso pubblico - Therese SørlieUlteriori informazioni
Non disponibili pubblicamente: 2
Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection
T Tramm, G Hennig, M Kyndi, J Alsner, FB Sørensen, S Myhre, T Sørlie, ...
Virchows Archiv 463, 775-786, 2013
Mandati: Danish Council for Technology and Innovation, Danish Council for Independent …
From autonomy to community; new perspectives on tumorigenicity and therapy resistance
N Skrbo, E Tenstad, GM Mælandsmo, T Sørlie, K Andersen
Cancer treatment reviews 41 (10), 809-813, 2015
Mandati: Science Foundation Ireland, Research Council of Norway
Disponibili pubblicamente: 29
Triple-negative breast cancer: present challenges and new perspectives
F Podo, LMC Buydens, H Degani, R Hilhorst, E Klipp, IS Gribbestad, ...
Molecular oncology 4 (3), 209-229, 2010
Mandati: Research Foundation (Flanders)
Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
VN Kristensen, CJ Vaske, J Ursini-Siegel, P Van Loo, SH Nordgard, ...
Proceedings of the National Academy of Sciences 109 (8), 2802-2807, 2012
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Research …
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
HG Russnes, HKM Vollan, OC Lingjærde, A Krasnitz, P Lundin, B Naume, ...
Science translational medicine 2 (38), 38ra47-38ra47, 2010
Mandati: Swedish Research Council, Cancer Research UK
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
X Tekpli, T Lien, AH Røssevold, D Nebdal, E Borgen, HO Ohnstad, ...
Nature communications 10 (1), 5499, 2019
Mandati: Research Council of Norway
Re-definition of claudin-low as a breast cancer phenotype
C Fougner, H Bergholtz, JH Norum, T Sørlie
Nature communications 11 (1), 1787, 2020
Mandati: Research Council of Norway
Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
J Kim, R Villadsen, T Sørlie, L Fogh, SZ Grønlund, AJ Fridriksdottir, I Kuhn, ...
Proceedings of the National Academy of Sciences 109 (16), 6124-6129, 2012
Mandati: US National Institutes of Health
Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer
R Lesurf, MR Aure, HH Mørk, V Vitelli, T Sauer, J Geisler, S Hofvind, ...
Cell reports 16 (4), 1166-1179, 2016
Mandati: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the …
T Tramm, H Mohammed, S Myhre, M Kyndi, J Alsner, AL Børresen-Dale, ...
Clinical Cancer Research 20 (20), 5272-5280, 2014
Mandati: Danish Council for Independent Research, Danish Council for Strategic …
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins
S Myhre, OC Lingjærde, BT Hennessy, MR Aure, MS Carey, J Alsner, ...
Molecular oncology 7 (3), 704-718, 2013
Mandati: US National Institutes of Health
LIMT is a novel metastasis inhibiting lnc RNA suppressed by EGF and downregulated in aggressive breast cancer
A Sas‐Chen, MR Aure, L Leibovich, S Carvalho, Y Enuka, C Körner, ...
EMBO molecular medicine 8 (9), 1052-1064, 2016
Mandati: US National Institutes of Health, German Research Foundation, Helmholtz …
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
S Borgquist, W Zhou, K Jirström, RM Amini, T Sollie, T Sørlie, C Blomqvist, ...
BMC cancer 15, 1-10, 2015
Mandati: Swedish Research Council
Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler
H Bergholtz, JM Carter, A Cesano, MCU Cheang, SE Church, P Divakar, ...
Cancers 13 (17), 4456, 2021
Mandati: US National Institutes of Health
Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post …
T Tramm, M Kyndi, S Myhre, S Nord, J Alsner, FB Sørensen, T Sørlie, ...
Acta Oncologica 53 (10), 1337-1346, 2014
Mandati: Danish Council for Independent Research, Danish Council for Strategic Research
Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
X Zhao, EA Rødland, T Sørlie, HKM Vollan, HG Russnes, VN Kristensen, ...
BMC cancer 14, 1-12, 2014
Mandati: Research Council of Norway
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
J Staaf, J Häkkinen, C Hegardt, LH Saal, S Kimbung, I Hedenfalk, T Lien, ...
NPJ breast cancer 8 (1), 94, 2022
Mandati: Swedish Research Council
In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome
S Myhre, H Mohammed, T Tramm, J Alsner, G Finak, M Park, J Overgaard, ...
PloS one 5 (11), e14002, 2010
Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology
JH Norum, E Skarpen, A Brech, R Kuiper, J Waaler, S Krauss, T Sørlie
Biological research 51, 1-13, 2018
Mandati: Science Foundation Ireland, Research Council of Norway
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy–results from two …
T Laurberg, T Tramm, T Nielsen, J Alsner, S Nord, S Myhre, T Sørlie, ...
Acta Oncologica 57 (1), 38-43, 2018
Mandati: US National Institutes of Health, Danish Council for Strategic Research
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software